EVMN
Evommune, Inc.
9.70$
+3.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| 100.0% | 100.0% | 100.0% | |
| 20.0% | 18.4% | 10.7% | |
| 80.0% | 81.6% | 100.0% | |
| 639.9% | 917.8% | 569.6% | |
| – | – | 154.1% | |
| 837.0% | 1,081.8% | 723.6% | |
| -757.0% | -1,000.2% | -623.6% | |
| 1.2% | 0.5% | 0.1% | |
| -681.1% | -954.4% | -529.8% | |
| -681.1% | -954.4% | -529.8% | |
| -659.9% | -935.5% | -519.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.